197 related articles for article (PubMed ID: 10987352)
1. Effects of antihypertensive therapy on blood pressure and left ventricular hypertrophy in patients with severe hypertension.
Sumino H; Nakamura T; Kanda T; Sakamaki T; Sato K; Saito Y; Hoshino J; Kurashina T; Ono Z; Takahashi T; Ichikawa S; Kurabayashi M; Nagai R
Jpn Heart J; 2000 May; 41(3):339-48. PubMed ID: 10987352
[TBL] [Abstract][Full Text] [Related]
2. Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.
Wachtell K; Bella JN; Rokkedal J; Palmieri V; Papademetriou V; Dahlöf B; Aalto T; Gerdts E; Devereux RB
Circulation; 2002 Mar; 105(9):1071-6. PubMed ID: 11877357
[TBL] [Abstract][Full Text] [Related]
3. Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy.
Solomon SD; Appelbaum E; Manning WJ; Verma A; Berglund T; Lukashevich V; Cherif Papst C; Smith BA; Dahlöf B;
Circulation; 2009 Feb; 119(4):530-7. PubMed ID: 19153265
[TBL] [Abstract][Full Text] [Related]
4. Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension.
Takami T; Shigematsu M
Clin Exp Hypertens; 2003 Nov; 25(8):525-35. PubMed ID: 14649310
[TBL] [Abstract][Full Text] [Related]
5. Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise.
Ketelhut S; Franz IW; Ketelhut RG
High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):385-390. PubMed ID: 30341642
[TBL] [Abstract][Full Text] [Related]
6. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
Rakić D; Rumboldt Z; Bagatin J; Polić S
Croat Med J; 2002 Dec; 43(6):672-9. PubMed ID: 12476475
[TBL] [Abstract][Full Text] [Related]
7. Losartan reduces left ventricular hypertrophy proportionally to blood pressure reduction in hypertensives, but does not affect diastolic cardiac function.
Zakynthinos E; Pierutsakos Ch; Konstantinidis K; Zakynthinos S; Papadogiannis D
Angiology; 2004; 55(6):669-78. PubMed ID: 15547653
[TBL] [Abstract][Full Text] [Related]
8. Improvement of diastolic function after regression of left ventricular hypertrophy.
Teniente-Valente R; Solorio S; Vargas-Salado E; Aguirre-Vázquez C; Hernández-González MA; Olvera-Lopez JA; Rodríguez-Mariscal L; Luna-Ruiz MA; Guillén Contreras JM; Murillo Ortiz BO
Arch Cardiol Mex; 2008; 78(4):392-9. PubMed ID: 19205547
[TBL] [Abstract][Full Text] [Related]
9. [The effect of hypotensive drugs on left ventricular mass and diastolic function].
Spring A; Haczyński J; Jołda-Mydłowska B; Witkowska M
Pol Arch Med Wewn; 1995 Jul; 94(1):47-58. PubMed ID: 8524699
[TBL] [Abstract][Full Text] [Related]
10. Hydrochlorothiazide is superior to isradipine for reduction of left ventricular mass: results of a multicenter trial. The Isradipine Study Group.
Papademetriou V; Gottdiener JS; Narayan P; Cushman WG; Zachariah PK; Gottdiener PS; Chase GA
J Am Coll Cardiol; 1997 Dec; 30(7):1802-8. PubMed ID: 9385910
[TBL] [Abstract][Full Text] [Related]
11. Change in systolic left ventricular performance after 3 years of antihypertensive treatment: the Losartan Intervention for Endpoint (LIFE) Study.
Wachtell K; Palmieri V; Olsen MH; Gerdts E; Papademetriou V; Nieminen MS; Smith G; Dahlöf B; Aurigemma GP; Devereux RB
Circulation; 2002 Jul; 106(2):227-32. PubMed ID: 12105163
[TBL] [Abstract][Full Text] [Related]
12. [Effect of cilazapril therapy on diastolic filling and left ventricular hypertrophy in patients with arterial hypertension].
De Simone R; Irace L; Perna B; Caruso C; Guida M; Iacono A
Minerva Cardioangiol; 1993 May; 41(5):205-9. PubMed ID: 8355860
[TBL] [Abstract][Full Text] [Related]
13. Effect of cilnidipine on left ventricular diastolic function in hypertensive patients as assessed by pulsed Doppler echocardiography and pulsed tissue Doppler imaging.
Onose Y; Oki T; Yamada H; Manabe K; Kageji Y; Matsuoka M; Yamamoto T; Tabata T; Wakatsuki T; Ito S
Jpn Circ J; 2001 Apr; 65(4):305-9. PubMed ID: 11316128
[TBL] [Abstract][Full Text] [Related]
14. Nurse-recorded and ambulatory blood pressure predicts treatment-induced reduction of left ventricular hypertrophy equally well in hypertension: results from the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) study.
Nyström F; Malmqvist K; Ohman KP; Kahan T
J Hypertens; 2002 Aug; 20(8):1527-33. PubMed ID: 12172314
[TBL] [Abstract][Full Text] [Related]
15. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH
Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164
[TBL] [Abstract][Full Text] [Related]
16. Impact of isolated systolic hypertension on normalization of left ventricular structure during antihypertensive treatment (the LIFE study).
Mancusi C; Gerdts E; De Simone G; Abdelhai YM; Lønnebakken MT; Boman K; Wachtell K; Dahlöf B; Devereux RB
Blood Press; 2014 Aug; 23(4):206-12. PubMed ID: 24564262
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of multielectrode renal denervation on cardiac adaptations in resistant hypertensive patients with left ventricular hypertrophy.
Tsioufis C; Papademetriou V; Dimitriadis K; Kasiakogias A; Kordalis A; Andrikou E; Milkas A; Liatakis I; Lau EO; Tousoulis D
J Hum Hypertens; 2016 Nov; 30(11):714-719. PubMed ID: 26818805
[TBL] [Abstract][Full Text] [Related]
18. Changes in left ventricular geometry during antihypertensive treatment.
Salvetti M; Paini A; Bertacchini F; Stassaldi D; Aggiusti C; Agabiti Rosei C; Bassetti D; Agabiti-Rosei E; Muiesan ML
Pharmacol Res; 2018 Aug; 134():193-199. PubMed ID: 29959031
[TBL] [Abstract][Full Text] [Related]
19. Optimal control of blood pressure can reverse left ventricular hypertrophy in uremic hypertensive hemodialysis patients.
Wu SG; Lin SL; Wu CM; Jeng FR; Su CZ
Kaohsiung J Med Sci; 1999 Feb; 15(2):62-8. PubMed ID: 10089714
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular mass regression in the LIFE study: effect of previous antihypertensive treatment.
Aurigemma GP; Devereux RB; Wachtell K; Palmieri V; Boman K; Gerdts E; Nieminen MS; Papademetriou V; Dahlöf B
Am J Hypertens; 2003 Mar; 16(3):180-6. PubMed ID: 12620695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
